Bio Rad Laboratories Inc當前公司基本面數據相對健康,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名149/208位。機構持股佔比非常低,近一個月,市場表現一般,但基本面評分較高。
Bio Rad Laboratories Inc評分
相關信息
行業排名
149 / 208
全市場排名
402 / 4582
所屬行業
醫療設備與耗材
壓力支撐
由於公司未披露,未能獲取相關數據
多維評測
本期評分
上期評分
分析師目標
基於
0
分析師
--
評級
0.000
目標均價
0.00%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議
Bio Rad Laboratories Inc亮點
亮點風險
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
公司代碼BIOb
公司Bio Rad Laboratories Inc
CEOSchwartz (Norman D)
網址https://www.bio-rad.com/
常見問題
Bio Rad Laboratories Inc(BIOb)的當前股價是多少?
Bio Rad Laboratories Inc(BIOb)的當前股價是 300.500。
Bio Rad Laboratories Inc 的股票代碼是什麼?
Bio Rad Laboratories Inc的股票代碼是BIOb。
Bio Rad Laboratories Inc股票的52週最高點是多少?
Bio Rad Laboratories Inc股票的52週最高點是359.220。
Bio Rad Laboratories Inc股票的52週最低點是多少?
Bio Rad Laboratories Inc股票的52週最低點是225.290。
Bio Rad Laboratories Inc的市值是多少?
Bio Rad Laboratories Inc的市值是8.11B。
Bio Rad Laboratories Inc的淨利潤是多少?
Bio Rad Laboratories Inc的淨利潤為-1.84B。
現在Bio Rad Laboratories Inc(BIOb)的股票是買入、持有還是賣出?
根據分析師評級,Bio Rad Laboratories Inc(BIOb)的總體評級為--,目標價格為--。
Bio Rad Laboratories Inc(BIOb)股票的每股收益(EPS TTM)是多少
Bio Rad Laboratories Inc(BIOb)股票的每股收益(EPS TTM)是-24.014。